Risk factors and appropriate therapeutic strategies for thrombotic microangiopathy after allogeneic HSCT.
Matsui H, Arai Y, Imoto H, Mitsuyoshi T, Tamura N, Kondo T, Kanda J, Ishikawa T, Imada K, Ueda Y, Toda Y, Anzai N, Yago K, Nohgawa M, Yonezawa A, Tsunemine H, Itoh M, Yamamoto K, Tsuji M, Moriguchi T, Takaori-Kondo A; Kyoto Stem Cell Transplantation Group (KSCTG).
Matsui H, et al.
Blood Adv. 2020 Jul 14;4(13):3169-3179. doi: 10.1182/bloodadvances.2020002007.
Blood Adv. 2020.
PMID: 32658984
Free PMC article.